Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04913129 · ClinicalTrials.gov registry record · NA
The Burden of COVID-19 Survivorship
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04913129: Completed NA study, sponsored by Mayo Clinic.
NCT04913129 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04913129, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This research study is being done to find out what the longer-term physiological consequences of COVID-19 are, and to determine if exercise therapy can help improve lung function, heart function and overall fitness, and reduce symptoms in people recovering from SARS-CoV-2.
Interventions
- OTHER Exercise Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04913129
The ClinicalTrials.gov registry entry for NCT04913129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Training is the first listed.
NCT04913129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04913129 about?
NCT04913129 is a clinical study titled "The Burden of COVID-19 Survivorship". This research study is being done to find out what the longer-term physiological consequences of COVID-19 are, and to determine if exercise therapy can help improve lung function, heart function and overall fitness, and reduce symptoms in people recovering from SARS-CoV-2.
What is the current status of trial NCT04913129?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-11-04. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04913129?
The interventions under investigation include: Exercise Training (OTHER).
Who is sponsoring clinical trial NCT04913129?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.